Needleless Ebola vaccine succeeds in monkeys; Vanderbilt University Medical Center becomes first scientific hub for Human Vaccines Project;

> The University of Texas Medical Branch at Galveston and the NIH tested an inhaled Ebola vaccine, which showed promise in monkeys and should move into human trials soon. Story

> Vanderbilt University Medical Center has become the first scientific hub for the Human Vaccines Project, incubated by the International AIDS Vaccine Initiative. Release

> Researchers at the University of Georgia have developed new tools to study the parasite that causes cryptosporidiosis. They hope to use them to develop treatments and vaccines for the disease. More

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.